137 related articles for article (PubMed ID: 21495440)
1. Antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: the evidence for treatment.
Jeffs LS; Hurtado PR; Faull RJ; Peh CA
Int J Evid Based Healthc; 2010 Mar; 8(1):18-27. PubMed ID: 21495440
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated vasculitis with renal involvement.
Binda V; Moroni G; Messa P
J Nephrol; 2018 Apr; 31(2):197-208. PubMed ID: 28560688
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Kidney Transplant in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Buttigieg J; Henderson L; Kidder D
Exp Clin Transplant; 2017 Oct; 15(5):509-515. PubMed ID: 27765007
[TBL] [Abstract][Full Text] [Related]
4. Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease.
Rhee RL; Hogan SL; Poulton CJ; McGregor JA; Landis JR; Falk RJ; Merkel PA
Arthritis Rheumatol; 2016 Jul; 68(7):1711-20. PubMed ID: 26814428
[TBL] [Abstract][Full Text] [Related]
5. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Morishita KA; Moorthy LN; Lubieniecka JM; Twilt M; Yeung RSM; Toth MB; Shenoi S; Ristic G; Nielsen SM; Luqmani RA; Li SC; Lee T; Lawson EF; Kostik MM; Klein-Gitelman M; Huber AM; Hersh AO; Foell D; Elder ME; Eberhard BA; Dancey P; Charuvanij S; Benseler SM; Cabral DA;
Arthritis Rheumatol; 2017 Jul; 69(7):1470-1479. PubMed ID: 28371513
[TBL] [Abstract][Full Text] [Related]
6. Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Zonozi R; Niles JL; Cortazar FB
Rheum Dis Clin North Am; 2018 Nov; 44(4):525-543. PubMed ID: 30274621
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.
Karras A; Pagnoux C; Haubitz M; Groot K; Puechal X; Tervaert JWC; Segelmark M; Guillevin L; Jayne D;
Ann Rheum Dis; 2017 Oct; 76(10):1662-1668. PubMed ID: 28546260
[TBL] [Abstract][Full Text] [Related]
8. Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis.
Flossmann O
Presse Med; 2015 Jun; 44(6 Pt 2):e251-7. PubMed ID: 26009242
[TBL] [Abstract][Full Text] [Related]
9. ANCA-associated renal vasculitis - an update.
Tesar V; Hruskova Z
Contrib Nephrol; 2013; 181():216-28. PubMed ID: 23689583
[TBL] [Abstract][Full Text] [Related]
10. [Uptodate in the management and treatment of ANCA-associated vasculitis].
Belaconi IN; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
[TBL] [Abstract][Full Text] [Related]
11. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
[No Abstract] [Full Text] [Related]
12. Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?
Tesar V; Hruskova Z
Expert Opin Pharmacother; 2015; 16(11):1683-702. PubMed ID: 26149512
[TBL] [Abstract][Full Text] [Related]
13. Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides.
Chaigne B; Guillevin L
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S121-8. PubMed ID: 27087528
[TBL] [Abstract][Full Text] [Related]
14. Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.
Kucuk A; Solak Y; Gaipov A; Bagcaci S; Esen H; Turk S; Tunc R
Korean J Intern Med; 2016 Jan; 31(1):194-6. PubMed ID: 26767877
[No Abstract] [Full Text] [Related]
15. [Acute on chronic renal failure in a 62-year-old man with ANCA-associated vasculitis].
Schroeder C; Schenk H; Khalifa A; Braesen JH; von Vietinghoff S
Internist (Berl); 2019 Oct; 60(10):1106-1110. PubMed ID: 31435719
[TBL] [Abstract][Full Text] [Related]
16. Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis.
Tomasson G
Curr Opin Rheumatol; 2015 Jan; 27(1):38-44. PubMed ID: 25405826
[TBL] [Abstract][Full Text] [Related]
17. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
Paolini MV; Ruffino JP; Fernández Romero DS
Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
[TBL] [Abstract][Full Text] [Related]
18. Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
Draibe J; Poveda R; Fulladosa X; Vidaller A; Zulberti C; Gomà M; Pujol R; Ripoll È; Torras J; Grinyó JM
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i132-7. PubMed ID: 25805744
[TBL] [Abstract][Full Text] [Related]
19. Pathology of Antineutrophil Cytoplasmic Antibody-Associated Pulmonary and Renal Disease.
Smith ML
Arch Pathol Lab Med; 2017 Feb; 141(2):223-231. PubMed ID: 28134583
[TBL] [Abstract][Full Text] [Related]
20. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.
McGregor JG; Negrete-Lopez R; Poulton CJ; Kidd JM; Katsanos SL; Goetz L; Hu Y; Nachman PH; Falk RJ; Hogan SL
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i171-81. PubMed ID: 25805747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
